<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03463642</url>
  </required_header>
  <id_info>
    <org_study_id>UoW116976</org_study_id>
    <nct_id>NCT03463642</nct_id>
  </id_info>
  <brief_title>The Efficacy of Different Vitamin D Supplementation Delivery Methods</brief_title>
  <official_title>The Efficacy of Different Vitamin D Supplementation Delivery Methods on Serum 25(OH)D in Humans a Randomised Double-blind Placebo Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wolverhampton</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Royal National Orthopaedic Hospital NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Worcester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Wolverhampton</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To test the efficacy of different vitamin D delivery methods on serum 25(OH)D. Participants
      randomly assigned to one of seven groups - three placebo groups and 4 active supplement
      groups receiving 100,000IU vitamin D3
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Various delivery methods of vitamin D supplementation are available to consumers but there
      have been no studies providing evidence of whether one delivery method is superior to others.
      The researchers wanted to compare the delivery of 100,000IU vitamin D3 by three methods on
      serum 25(OH)D levels. Two methods of oral supplementation (pill [prolonged release] and
      liquid [immediate release]), and delivery through the skin (with and without a penetrator
      enhancer. Placebo groups were pill, oral liquid and skin applied oil
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2, 2017</start_date>
  <completion_date type="Actual">April 4, 2017</completion_date>
  <primary_completion_date type="Actual">April 4, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum 25(OH)D</measure>
    <time_frame>4 weeks</time_frame>
    <description>Changes in serum 25(OH)D levels</description>
  </primary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>Vitamin D3 pill</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100 pills = 100,000IU + Dicalcium phosphate, microcrystalline cellulose, silicium dioxide, magnesium stearate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pill placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>100 pills = Dicalcium phosphate, microcrystalline cellulose, silicium dioxide, magnesium stearate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D3 oral liquid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100 drops = 100,000IU in orange syrup</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral liquid placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>100 drops orange syrup</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Skin oil + Vitamin D3 + penetrator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100,000IU + mineral oil+ Tangerine essential oil (10ml)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Skin oil + Vitamin D3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100,000IU + mineral oil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Skin oil placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Skin application: 100ml of mineral oil coloured with food colourant to match active oil sample</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D3</intervention_name>
    <description>100,000IU</description>
    <arm_group_label>Vitamin D3 pill</arm_group_label>
    <arm_group_label>Vitamin D3 oral liquid</arm_group_label>
    <arm_group_label>Skin oil + Vitamin D3 + penetrator</arm_group_label>
    <arm_group_label>Skin oil + Vitamin D3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Pill</intervention_name>
    <description>Dicalcium phosphate, microcrystalline cellulose, silicium dioxide, magnesium stearate</description>
    <arm_group_label>Vitamin D3 pill</arm_group_label>
    <arm_group_label>Pill placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>orange syrup</intervention_name>
    <description>100 drops orange syrup</description>
    <arm_group_label>Vitamin D3 oral liquid</arm_group_label>
    <arm_group_label>Oral liquid placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>mineral oil</intervention_name>
    <description>Paraffinum Liquidum,Isopropyl Palmitate,Parfum</description>
    <arm_group_label>Skin oil + Vitamin D3 + penetrator</arm_group_label>
    <arm_group_label>Skin oil + Vitamin D3</arm_group_label>
    <arm_group_label>Skin oil placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Penetrator</intervention_name>
    <description>Tangerine essential oil (10ml)</description>
    <arm_group_label>Skin oil + Vitamin D3 + penetrator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy, female

        Exclusion Criteria:

          -  any participant that was taking vitamin supplementation, had a skin condition that
             would prevent them from applying oil to their skin or were taking, or had been taking
             in the past 6-months, oestrogen based contraception
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Wolverhampton</name>
      <address>
        <city>Walsall</city>
        <state>West Midlands</state>
        <zip>WS1 3BD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <results_reference>
    <citation>Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011 Jan;96(1):53-8. doi: 10.1210/jc.2010-2704. Epub 2010 Nov 29.</citation>
    <PMID>21118827</PMID>
  </results_reference>
  <results_reference>
    <citation>Stoll D, Dudler J, Lamy O, Hans D, Krieg MA, Aubry-Rozier B. Can one or two high doses of oral vitamin D3 correct insufficiency in a non-supplemented rheumatologic population? Osteoporos Int. 2013 Feb;24(2):495-500. doi: 10.1007/s00198-012-1962-5. Epub 2012 Mar 17.</citation>
    <PMID>22426953</PMID>
  </results_reference>
  <results_reference>
    <citation>Leventis P, Kiely PD. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scand J Rheumatol. 2009 Mar-Apr;38(2):149-53. doi: 10.1080/03009740802419081.</citation>
    <PMID>18991184</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2018</study_first_submitted>
  <study_first_submitted_qc>March 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2018</study_first_posted>
  <last_update_submitted>March 12, 2018</last_update_submitted>
  <last_update_submitted_qc>March 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Wolverhampton</investigator_affiliation>
    <investigator_full_name>Matthew Wyon</investigator_full_name>
    <investigator_title>Professor Matthew Wyon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Mineral Oil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

